The Kaiser Permanente Augmented Intelligence in Medicine and Healthcare Initiative (AIM-HI) Coordinating Center, part of the Kaiser Permanente Northern California Division of Research, has awarded funding to five healthcare organizations. These grants, supported by the Gordon and Betty Moore Foundation, provide up to $750,000 for each organization to research artificial intelligence (AI) and machine learning (ML) applications in enhancing diagnostic decision-making.
AIM-HI, focusing on rigorously evaluating AI and ML in health care, received over 120 applications covering various AI and ML applications, including predictive models and computer vision. The initiative, led by Dr. Vincent Liu, selected projects for their innovative impact across diverse technologies and patient groups.
The recipients are:
- Dr. Cesar Termulo, Jr. from Parkland Health, Dallas, focuses on pediatric asthma care in safety net health settings.
- Dr. David Ouyang from The Smidt Heart Institute at Cedars-Sinai Medical Center, Los Angeles, for identifying cardiac amyloidosis in diverse populations.
- Dr. Sivasubramanium Bhavani from Emory University, Atlanta, works on precision sepsis resuscitation.
- Dr. Fatima Munoz from San Ysidro Health, San Diego, for diabetic retinopathy screening.
- Dr. Peter J. Embí from Vanderbilt University Medical Center, Nashville, focuses on AI-enabled diagnosis.
These projects, spanning three years, aim to advance AI and ML in health care, with the AIM-HI Coordinating Center and Advisory Committee providing support and sharing best practices. This initiative reflects Kaiser Permanente’s long-standing commitment to data-driven patient care and its vision to support diverse healthcare organizations in assessing AI and ML in various settings.
To read more, click here.
[Source: PR Newswire, December 18th, 2023]